BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35999388)

  • 1. Clinical characteristics and treatment of NK/T-cell lymphoma-associated HLH.
    Meng G; Wang J; Cui T; Wang Z
    Ann Hematol; 2022 Oct; 101(10):2289-2296. PubMed ID: 35999388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    He Y; Gao Y; Ping L; He H; Huang C; Bai B; Wang X; Li Z; Cai Q; Huang Y; Pan X; Zeng W; Liu Y; Huang H
    J Cancer Res Clin Oncol; 2023 May; 149(5):2017-2027. PubMed ID: 35809114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DEP regimen is superior to the HLH-1994 regimen as first-line therapy for lymphoma-associated haemophagocytic lymphohistiocytosis.
    Meng G; Wang Y; Wang J; Wang Z
    Leuk Lymphoma; 2021 Apr; 62(4):854-860. PubMed ID: 33225788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
    Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome].
    Zhao AL; Li M; Li LF; Gan XA; Wang J; Li H; Shen K; Yang YF; Niu T
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2173-2180. PubMed ID: 35872581
    [No Abstract]   [Full Text] [Related]  

  • 7. Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study.
    Pi Y; Wang J; Zhou H; Ye X; Sun X; Liu L; Pan X; Wang Z
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3033-3041. PubMed ID: 35852619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-associated hemophagocytic lymphohistiocytosis secondary to NK/T cells lymphoma: A case report and literature review.
    He M; Jia J; Zhang J; Beejadhursing R; Mwamaka Sharifu L; Yu J; Wang S; Feng L
    Medicine (Baltimore); 2017 Nov; 96(47):e8628. PubMed ID: 29381934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
    Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
    Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.
    Zhou L; Liu Y; Wen Z; Yang S; Li M; Zhu Q; Qiu S; Gao Y; Wang H; Yuan Y; Zhang H; Chen C; Zeng W; Guan Z; Pan X
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):3063-3074. PubMed ID: 32617699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
    Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
    Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z
    Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to T Cell Lymphoma and Cytomegalovirus (CMV) Infection and Complicated by Tumor Lysis Syndrome (TLS).
    Kilani Y; Laxamana T; Mahfooz K; Yusuf MH; Perez-Gutierrez V; Shabarek N
    Am J Case Rep; 2022 Apr; 23():e935915. PubMed ID: 35361746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study.
    Li B; Guo J; Li T; Gu J; Zeng C; Xiao M; Zhang W; Li Q; Zhou J; Zhou X
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e198-e205. PubMed ID: 33303420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Liu YZ; Bi LQ; Chang GL; Guo Y; Sun S
    Cancer Manag Res; 2019; 11():997-1002. PubMed ID: 30774427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.
    Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ
    Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
    Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
    Front Immunol; 2022; 13():882589. PubMed ID: 35479073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma.
    Liu Y; Sardana R; Nemirovsky D; Frosina D; Jungbluth A; Johnson WT; Vardhana S; Arcila M; Horwitz SM; Derkach A; Dogan A; Xiao W
    Blood Adv; 2024 Jun; 8(12):3064-3075. PubMed ID: 38593227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic active EBV infection associated with NK cell lymphoma and hemophagocytic lymphohistiocytosis in a 27-year-old woman: A case report.
    Wang YD; Wu LL; Ma LY; Shang XB; Li ZY; Wang W; Shen C; Yang JJ; Sun LX; Zhao CY
    Medicine (Baltimore); 2019 Jan; 98(2):e14032. PubMed ID: 30633196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
    Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
    Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.